Synthesis and structure-activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors

被引：32

作者：

Gilmore, JL ^{[1
]}

King, BW ^{[1
]}

Harris, C ^{[1
]}

Maduskuie, T ^{[1
]}

Mercer, SE ^{[1
]}

Liu, RQ ^{[1
]}

Covington, MB ^{[1
]}

Qian, MX ^{[1
]}

Ribadeneria, MD ^{[1
]}

Vaddi, K ^{[1
]}

Trzaskos, JM ^{[1
]}

Newton, RC ^{[1
]}

Decicco, CP ^{[1
]}

Duan, JJW ^{[1
]}

机构：

[1] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08540 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 10期

关键词：

TACE inhibitors; metazincin; metalloprotease; sheddase; tumor necrosis factor; antiinflammatory; hydroxamic acid;

D O I：

10.1016/j.bmcl.2006.02.015

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of achiral TNF-alpha converting enzyme (TACE) inhibitors has been discovered. These compounds exhibited activities from 0.35 to 11 nM in a porcine TACE assay and inhibited TNF-alpha production in an LPS-stimulated whole blood assay with an IC50 value of 23 nM for the most potent one. They also have excellent selectivities over related metalloproteases including aggrecanases. (C) 2006 Elsevier Ltd. All rights reserved.

引用

页码：2699 / 2704

页数：6

共 39 条

[1]

AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345

[2]

Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93

[3] A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].

Black, RA ;

Rauch, CT ;

Kozlosky, CJ ;

Peschon, JJ ;

Slack, JL ;

Wolfson, MF ;

Castner, BJ ;

Stocking, KL ;

Reddy, P ;

Srinivasan, S ;

Nelson, N ;

Boiani, N ;

Schooley, KA ;

Gerhart, M ;

Davis, R ;

Fitzner, JN ;

Johnson, RS ;

Paxton, RJ ;

March, CJ ;

Cerretti, DP .

NATURE, 1997, 385 (6618) :729-733

[4] Anthranilate sulfonamide hydroxamate TACE inhibitors.: Part 1:: Structure-based design of novel acetylenic P1′ groups [J].

Chen, JM ;

Jin, GX ;

Sung, A ;

Levin, JI .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (08) :1195-1198

[5] Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-α converting enzyme inhibitors [J].

Cherney, RJ ;

Duan, JJW ;

Voss, ME ;

Chen, LH ;

Wang, L ;

Meyer, DT ;

Wasserman, ZR ;

Hardman, KD ;

Liu, RQ ;

Covington, MB ;

Qian, MX ;

Mandlekar, S ;

Christ, DD ;

Trzaskos, JM ;

Newton, RC ;

Magolda, RL ;

Wexler, RR ;

Decicco, CP .

JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (10) :1811-1823

[6]

DUAN J, UNPUB

[7] Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-α converting enzyme [J].

Duan, JJW ;

Lu, ZH ;

Wasserman, ZR ;

Liu, RQ ;

Covington, MB ;

Decicco, CP .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) :2970-2973

[8] Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-α converting enzyme (TACE) [J].

Duan, JJW ;

Lu, ZH ;

Xue, CB ;

He, XH ;

Seng, JL ;

Roderick, JJ ;

Wasserman, ZR ;

Liu, RQ ;

Covington, MB ;

Magolda, RL ;

Newton, RC ;

Trzaskos, JM ;

Decicco, CP .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (12) :2035-2040

[9] Discovery of γ-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor α converting enzyme:: Design, synthesis, and structure-activity relationships [J].

Duan, JJW ;

Chen, LH ;

Wasserman, ZR ;

Lu, ZH ;

Liu, RQ ;

Covington, MB ;

Qian, MX ;

Hardman, KD ;

Magolda, RL ;

Newton, RC ;

Christ, DD ;

Wexler, RR ;

Decicco, CP .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :4954-4957

[10] Taming TNF: strategies to restrain this proinflammatory cytokine [J].

Eigler, A ;

Sinha, B ;

Hartmann, G ;

Endres, S .

IMMUNOLOGY TODAY, 1997, 18 (10) :487-492

← 1 2 3 4 →